On March 6, a U.S. Senate committee on Homeland Security and Governmental Affairs will hold a hearing on a bill that would prohibit federal agencies from contracting with China’s BGI, WuXi AppTec, according to Reuters. A U.S. Committee is seeking sanctions on WuXi AppTec and its affiliate WuXi Biologics, according to a letter dated February 12 and seen by Reuters, stating that the global pharmaceutical company’s links to China’s Communist Party (CCP) and military threatened U.S. n...